Drug intelligence / Profile preview

etodolac + lidocaine

Development stage
Phase 3
Lead developer
MEDRx
Modality
Small Molecules
Administration
Topical
01

Overview

Etodolac + lidocaine is a combination of two pharmaceutical agents commonly used for pain management. Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins involved in inflammation and pain[1][3][4][6]. It is primarily indicated for the treatment of mild to moderate pain, osteoarthritis, and rheumatoid arthritis[1][3][5]. Lidocaine is a local anesthetic that blocks sodium channels in neuronal cell membranes, preventing nerve impulse conduction and thereby providing local numbness or analgesia. The combination may be used topically or in compounded preparations to provide both anti-inflammatory effects from etodolac and local anesthesia from lidocaine.

Brand names
Etoreat
Other names
EtoreatLidocaine/etodolacMRX-7EATMRX7EATMRX 7EAT
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on etodolac + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on etodolac + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call